Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Jun-23 5:00 PM View:  | Allogene Therapeutics, Inc. (ALLO) | 13-Jun-23 | Grant | 74,561 | -- | -- | 34% 218.27K to 292.83K | |
| 15-Aug-22 5:12 PM View: | Allogene Therapeutics, Inc. (ALLO) | 12-Aug-22 | Sale | 5,000 | $17.25 | $86,250.00 | (2%) 223.27K to 218.27K | |
| 15-Aug-22 5:40 PM View: | Allogene Therapeutics, Inc. (ALLO) | 12-Aug-22 | Sale Duplicate | 5,000 | $17.25 | $86,250.00 | (2%) 223.27K to 218.27K | |
| 15-Aug-22 5:12 PM View: | Allogene Therapeutics, Inc. (ALLO) | 11-Aug-22 | Private Sale | 10,000 | $16.50 | $165,000.00 | (4%) 233.27K to 223.27K | |
| 15-Aug-22 5:40 PM View: | Allogene Therapeutics, Inc. (ALLO) | 11-Aug-22 | Private Sale Duplicate | 10,000 | $16.50 | $165,000.00 | (4%) 233.27K to 223.27K | |
| 23-Jun-22 4:40 PM View: | Allogene Therapeutics, Inc. (ALLO) | 22-Jun-22 | Market Sale | 10,000 | $11.76 | $117,600.00 | (4%) 243.27K to 233.27K | (4%) |
| 17-Jun-22 4:58 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Jun-22 | Grant | 22,089 | -- | -- | 10% 221.18K to 243.27K | |
| 09-Sep-21 5:32 PM View: | Allogene Therapeutics, Inc. (ALLO) | 09-Sep-21 | Market Sale | 5,000 | $25.54 | $127,700.00 | (2%) 226.18K to 221.18K | 2% |
| 23-Aug-21 4:22 PM View: | Allogene Therapeutics, Inc. (ALLO) | 20-Aug-21 | Market Sale | 10,000 | $23.47 | $234,700.00 | (4%) 236.18K to 226.18K | < 1% |
| 11-Jun-21 5:48 PM View: | Allogene Therapeutics, Inc. (ALLO) | 09-Jun-21 | Market Sale | 9,969 | $25.05 | $249,723.00 | (4%) 246.15K to 236.18K | (4%) |
| 09-Jun-20 4:06 PM View: | Allogene Therapeutics, Inc. (ALLO) | 05-Jun-20 | Grant | 9,969 | -- | -- | 4% 236.18K to 246.15K | |
| 17-Oct-18 5:32 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Oct-18 | Conversion | 37,432 | -- | -- | 20% 183.75K to 221.18K | |
| 17-Oct-18 5:32 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Oct-18 | Purchase | 15,000 | $18.00 | $270,000.00 | 7% 221.18K to 236.18K | |
| 05-Oct-17 8:19 PM View: | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 5,715 | -- | -- | (9%) 64.25K to 58.53K | |
| 05-Oct-17 8:19 PM View: | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition (change in control) | 58,535 | $180.00 | $10,536,300.00 | (100%) 58.53K to 0 | |
| 05-Oct-17 8:19 PM View: | Kite Pharma, Inc. (KITE) | 18-Sep-17 | Gift | 12,000 | -- | -- | (16%) 76.25K to 64.25K | |
| 26-Jun-17 7:55 PM View: | Kite Pharma, Inc. (KITE) | 26-Jun-17 | Market Sale | 12,500 | $100.60 | $1,257,500.00 | (14%) 88.75K to 76.25K | (79%) |
| 26-Jun-17 7:55 PM View: | Kite Pharma, Inc. (KITE) | 23-Jun-17 | Option Exercise | 12,500 | $18.00 | $225,000.00 | 14% 88.75K to 101.25K | |
| 26-Jun-17 7:55 PM View: | Kite Pharma, Inc. (KITE) | 23-Jun-17 | Market Option Sale (Planned) | 12,500 | $100.00 | $1,250,000.00 | (12%) 101.25K to 88.75K | (80%) |
| 22-Jun-17 2:33 PM View: | Kite Pharma, Inc. (KITE) | 20-Jun-17 | Grant | 2,410 | -- | -- | 3% 86.34K to 88.75K | |
| 16-Mar-17 5:13 PM View: | Kite Pharma, Inc. (KITE) | 14-Mar-17 | Grant | 4,690 | -- | -- | 6% 81.65K to 86.34K |